In breast cancer, a large number of studies have investigated Cathepsin D expression using either immunohistochemistry or measurement of cytosolic Cathepsin D content (by radiometric immunoassay (IRMA), ELISA or Western blot). This evidence concerns the gene CTSD and breast cancer.